Metraipolis › archive › dc_1565bcf0ca8f

Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients — Europe PMC PMID:42792857

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42792857
DOI
10.3390/biomedicines14092117
License (as archived)
solo-consultazione
Archived
2026-10-08T03:16:02.214Z
SHA-256 of the archived text
5280ce3e19c0b0fefc0192506e5cffe13935c465d14abe4fa65606b9b8a183bc
Stable URL of this page
https://metraipolis.com/documento/dc_1565bcf0ca8f

How to cite

Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients — Europe PMC PMID:42792857 — Europe PMC (en), https://europepmc.org/article/MED/42792857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1565bcf0ca8f (Metraipolis archive dc_1565bcf0ca8f, sha256 5280ce3e19c0b0fefc0192506e5cffe13935c465d14abe4fa65606b9b8a183bc)
BibTeX
@misc{dc1565bcf0ca8f,
  title = {Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients — Europe PMC PMID:42792857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42792857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1565bcf0ca8f; sha256 5280ce3e19c0b0fefc0192506e5cffe13935c465d14abe4fa65606b9b8a183bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42792857. Agents can read the archived copy with the MCP tool read_document.